Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 1997 Apr 1;323(Pt 1):23–31. doi: 10.1042/bj3230023

Sequence-selective binding to DNA of bis(amidinophenoxy)alkanes related to propamidine and pentamidine.

C Bailly 1, D Perrine 1, J C Lancelot 1, C Saturnino 1, M Robba 1, M J Waring 1
PMCID: PMC1218299  PMID: 9173886

Abstract

The DNA sequences targeted by a complete homologous series of aromatic diamidines have been determined at single-nucleotide resolution via protection from cutting by the endonucleases DNase I, DNase II and micrococcal nuclease. Propamidine, pentamidine and to a lesser extent hexamidine bind selectively to nucleotide sequences composed of at least four consecutive A-T base pairs. In contrast, the binding to DNA of butamidine, heptamidine, octamidine and nonamidine is poorly sequence-selective. Sequences composed of only three consecutive A-T base pairs do not afford a potential binding site for propamidine or the longer homologues, and none of the drugs tolerate the presence of a G-C base pair within the binding site. Experiments with DNA molecules containing inosine in place of guanosine and 2,6-diaminopurine in place of adenine reveal that the lack of binding of propamidine to GC-containing sites is attributable to an obstructive effect of the exocyclic 2-amino group of guanosine. The present data support the view that the local conformation of the double helix (in particular the width of the minor groove) plays a dominant role in the binding reaction and that the capacity of diamidines to recognize AT-rich sequences selectively varies considerably depending on the length of the alkyl chain. The evidence indicates that binding to AT-tracts in DNA must play a role in the biological activity of these diamidines, but there is no simple correlation between binding and pharmacological efficacy.

Full Text

The Full Text of this article is available as a PDF (809.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baguley B. C. Nonintercalative DNA-binding antitumour compounds. Mol Cell Biochem. 1982 Apr 2;43(3):167–181. doi: 10.1007/BF00223008. [DOI] [PubMed] [Google Scholar]
  2. Bailly C., Donkor I. O., Gentle D., Thornalley M., Waring M. J. Sequence-selective binding to DNA of cis- and trans- butamidine analogues of the anti-Pneumocystis carinii pneumonia drug pentamidine. Mol Pharmacol. 1994 Aug;46(2):313–322. [PubMed] [Google Scholar]
  3. Bailly C., Møllegaard N. E., Nielsen P. E., Waring M. J. The influence of the 2-amino group of guanine on DNA conformation. Uranyl and DNase I probing of inosine/diaminopurine substituted DNA. EMBO J. 1995 May 1;14(9):2121–2131. doi: 10.1002/j.1460-2075.1995.tb07204.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bailly C., Payet D., Travers A. A., Waring M. J. PCR-based development of DNA substrates containing modified bases: an efficient system for investigating the role of the exocyclic groups in chemical and structural recognition by minor groove binding drugs and proteins. Proc Natl Acad Sci U S A. 1996 Nov 26;93(24):13623–13628. doi: 10.1073/pnas.93.24.13623. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bailly C., Waring M. J. Comparison of different footprinting methodologies for detecting binding sites for a small ligand on DNA. J Biomol Struct Dyn. 1995 Feb;12(4):869–898. doi: 10.1080/07391102.1995.10508782. [DOI] [PubMed] [Google Scholar]
  6. Bailly C., Waring M. J. Transferring the purine 2-amino group from guanines to adenines in DNA changes the sequence-specific binding of antibiotics. Nucleic Acids Res. 1995 Mar 25;23(6):885–892. doi: 10.1093/nar/23.6.885. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Bell C. A., Cory M., Fairley T. A., Hall J. E., Tidwell R. R. Structure-activity relationships of pentamidine analogs against Giardia lamblia and correlation of antigiardial activity with DNA-binding affinity. Antimicrob Agents Chemother. 1991 Jun;35(6):1099–1107. doi: 10.1128/aac.35.6.1099. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Bell C. A., Hall J. E., Kyle D. E., Grogl M., Ohemeng K. A., Allen M. A., Tidwell R. R. Structure-activity relationships of analogs of pentamidine against Plasmodium falciparum and Leishmania mexicana amazonensis. Antimicrob Agents Chemother. 1990 Jul;34(7):1381–1386. doi: 10.1128/aac.34.7.1381. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Braithwaite A. W., Baguley B. C. Existence of an extended series of antitumor compounds which bind to deoxyribonucleic acid by nonintercalative means. Biochemistry. 1980 Mar 18;19(6):1101–1106. doi: 10.1021/bi00547a009. [DOI] [PubMed] [Google Scholar]
  10. Broggini M., Ponti M., Ottolenghi S., D'Incalci M., Mongelli N., Mantovani R. Distamycins inhibit the binding of OTF-1 and NFE-1 transfactors to their conserved DNA elements. Nucleic Acids Res. 1989 Feb 11;17(3):1051–1059. doi: 10.1093/nar/17.3.1051. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Conte M. R., Jenkins T. C., Lane A. N. Interaction of minor-groove-binding diamidine ligands with an asymmetric DNA duplex. NMR and molecular modelling studies. Eur J Biochem. 1995 Apr 15;229(2):433–444. doi: 10.1111/j.1432-1033.1995.0433k.x. [DOI] [PubMed] [Google Scholar]
  12. Cory M., Tidwell R. R., Fairley T. A. Structure and DNA binding activity of analogues of 1,5-bis(4-amidinophenoxy)pentane (pentamidine) J Med Chem. 1992 Feb 7;35(3):431–438. doi: 10.1021/jm00081a003. [DOI] [PubMed] [Google Scholar]
  13. Donkor I. O., Tidwell R. R., Jones S. K. Pentamidine congeners. 2. 2-butene-bridged aromatic diamidines and diimidazolines as potential anti-Pneumocystis carinii pneumonia agents. J Med Chem. 1994 Dec 23;37(26):4554–4557. doi: 10.1021/jm00052a014. [DOI] [PubMed] [Google Scholar]
  14. Dorn A., Affolter M., Müller M., Gehring W. J., Leupin W. Distamycin-induced inhibition of homeodomain-DNA complexes. EMBO J. 1992 Jan;11(1):279–286. doi: 10.1002/j.1460-2075.1992.tb05050.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Drew H. R. Structural specificities of five commonly used DNA nucleases. J Mol Biol. 1984 Jul 15;176(4):535–557. doi: 10.1016/0022-2836(84)90176-1. [DOI] [PubMed] [Google Scholar]
  16. Edwards K. J., Jenkins T. C., Neidle S. Crystal structure of a pentamidine-oligonucleotide complex: implications for DNA-binding properties. Biochemistry. 1992 Aug 11;31(31):7104–7109. doi: 10.1021/bi00146a011. [DOI] [PubMed] [Google Scholar]
  17. Fairall L., Rhodes D. A new approach to the analysis of DNase I footprinting data and its application to the TFIIIA/5S DNA complex. Nucleic Acids Res. 1992 Sep 25;20(18):4727–4731. doi: 10.1093/nar/20.18.4727. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Ferguson L. R., Baguley B. C. Induction of petite mutants in yeast by non-intercalative DNA-binding antitumour agents. Eur J Cancer Clin Oncol. 1983 Nov;19(11):1575–1583. doi: 10.1016/0277-5379(83)90089-5. [DOI] [PubMed] [Google Scholar]
  19. Fox K. R., Sansom C. E., Stevens M. F. Footprinting studies on the sequence-selective binding of pentamidine to DNA. FEBS Lett. 1990 Jun 18;266(1-2):150–154. doi: 10.1016/0014-5793(90)81527-u. [DOI] [PubMed] [Google Scholar]
  20. Fox K. R., Waring M. J. DNA structural variations produced by actinomycin and distamycin as revealed by DNAase I footprinting. Nucleic Acids Res. 1984 Dec 21;12(24):9271–9285. doi: 10.1093/nar/12.24.9271. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Fox K. R., Waring M. J. The use of micrococcal nuclease as a probe for drug-binding sites on DNA. Biochim Biophys Acta. 1987 Jul 14;909(2):145–155. doi: 10.1016/0167-4781(87)90036-4. [DOI] [PubMed] [Google Scholar]
  22. Gambari R., Barbieri R., Nastruzzi C., Chiorboli V., Feriotto G., Natali P. G., Giacomini P., Arcamone F. Distamycin inhibits the binding of a nuclear factor to the -278/-256 upstream sequence of the human HLA-DR alpha gene. Biochem Pharmacol. 1991 Feb 15;41(4):497–502. doi: 10.1016/0006-2952(91)90620-k. [DOI] [PubMed] [Google Scholar]
  23. Gazzard B. G. Pneumocystis carinii pneumonia and its treatment in patients with AIDS. J Antimicrob Chemother. 1989 Jan;23 (Suppl A):67–75. doi: 10.1093/jac/23.suppl_a.67. [DOI] [PubMed] [Google Scholar]
  24. Goodisman J., Dabrowiak J. C. Structural changes and enhancements in DNase I footprinting experiments. Biochemistry. 1992 Feb 4;31(4):1058–1064. doi: 10.1021/bi00119a014. [DOI] [PubMed] [Google Scholar]
  25. Greenidge P. A., Jenkins T. C., Neidle S. DNA minor groove recognition properties of pentamidine and its analogs: a molecular modeling study. Mol Pharmacol. 1993 Jun;43(6):982–988. [PubMed] [Google Scholar]
  26. Jenkins T. C., Lane A. N., Neidle S., Brown D. G. NMR and molecular modeling studies of the interaction of berenil and pentamidine with d(CGCAAATTTGCG)2. Eur J Biochem. 1993 May 1;213(3):1175–1184. doi: 10.1111/j.1432-1033.1993.tb17868.x. [DOI] [PubMed] [Google Scholar]
  27. Johnston R. F., Pickett S. C., Barker D. L. Autoradiography using storage phosphor technology. Electrophoresis. 1990 May;11(5):355–360. doi: 10.1002/elps.1150110503. [DOI] [PubMed] [Google Scholar]
  28. Jones S. K., Hall J. E., Allen M. A., Morrison S. D., Ohemeng K. A., Reddy V. V., Geratz J. D., Tidwell R. R. Novel pentamidine analogs in the treatment of experimental Pneumocystis carinii pneumonia. Antimicrob Agents Chemother. 1990 Jun;34(6):1026–1030. doi: 10.1128/aac.34.6.1026. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Käs E., Izaurralde E., Laemmli U. K. Specific inhibition of DNA binding to nuclear scaffolds and histone H1 by distamycin. The role of oligo(dA).oligo(dT) tracts. J Mol Biol. 1989 Dec 5;210(3):587–599. doi: 10.1016/0022-2836(89)90134-4. [DOI] [PubMed] [Google Scholar]
  30. Lamond A. I., Travers A. A. Requirement for an upstream element for optimal transcription of a bacterial tRNA gene. Nature. 1983 Sep 15;305(5931):248–250. doi: 10.1038/305248a0. [DOI] [PubMed] [Google Scholar]
  31. Laughton C. A., Jenkins T. C., Fox K. R., Neidle S. Interaction of berenil with the tyrT DNA sequence studied by footprinting and molecular modelling. Implications for the design of sequence-specific DNA recognition agents. Nucleic Acids Res. 1990 Aug 11;18(15):4479–4488. doi: 10.1093/nar/18.15.4479. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Low C. M., Drew H. R., Waring M. J. Sequence-specific binding of echinomycin to DNA: evidence for conformational changes affecting flanking sequences. Nucleic Acids Res. 1984 Jun 25;12(12):4865–4879. doi: 10.1093/nar/12.12.4865. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Montgomery A. B., Debs R. J., Luce J. M., Corkery K. J., Turner J., Brunette E. N., Lin E. T., Hopewell P. C. Aerosolised pentamidine as sole therapy for Pneumocystis carinii pneumonia in patients with acquired immunodeficiency syndrome. Lancet. 1987 Aug 29;2(8557):480–483. doi: 10.1016/s0140-6736(87)91794-6. [DOI] [PubMed] [Google Scholar]
  34. Nunn C. M., Jenkins T. C., Neidle S. Crystal structure of d(CGCGAATTCGCG) complexed with propamidine, a short-chain homologue of the drug pentamidine. Biochemistry. 1993 Dec 21;32(50):13838–13843. doi: 10.1021/bi00213a012. [DOI] [PubMed] [Google Scholar]
  35. Nunn C. M., Jenkins T. C., Neidle S. Crystal structure of gamma-oxapentamidine complexed with d(CGCGAATTCGCG)2. The effects of drug structural change on DNA minor-groove recognition. Eur J Biochem. 1994 Dec 15;226(3):953–961. doi: 10.1111/j.1432-1033.1994.00953.x. [DOI] [PubMed] [Google Scholar]
  36. Perrine D., Chenu J. P., Georges P., Lancelot J. C., Saturnino C., Robba M. Amoebicidal efficiencies of various diamidines against two strains of Acanthamoeba polyphaga. Antimicrob Agents Chemother. 1995 Feb;39(2):339–342. doi: 10.1128/aac.39.2.339. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Portugal J., Waring M. J. Comparison of binding sites in DNA for berenil, netropsin and distamycin. A footprinting study. Eur J Biochem. 1987 Sep 1;167(2):281–289. doi: 10.1111/j.1432-1033.1987.tb13334.x. [DOI] [PubMed] [Google Scholar]
  38. Sands M., Kron M. A., Brown R. B. Pentamidine: a review. Rev Infect Dis. 1985 Sep-Oct;7(5):625–634. doi: 10.1093/clinids/7.5.625. [DOI] [PubMed] [Google Scholar]
  39. Sansom C. E., Laughton C. A., Neidle S., Schwalbe C. H., Stevens M. F. Structural studies on bio-active compounds. Part XIV. Molecular modelling of the interactions between pentamidine and DNA. Anticancer Drug Des. 1990 Aug;5(3):243–248. [PubMed] [Google Scholar]
  40. Sayers E. W., Waring M. J. Footprinting titration studies on the binding of echinomycin to DNA incapable of forming Hoogsteen base pairs. Biochemistry. 1993 Sep 7;32(35):9094–9107. doi: 10.1021/bi00086a014. [DOI] [PubMed] [Google Scholar]
  41. Shapiro T. A., Englund P. T. Selective cleavage of kinetoplast DNA minicircles promoted by antitrypanosomal drugs. Proc Natl Acad Sci U S A. 1990 Feb;87(3):950–954. doi: 10.1073/pnas.87.3.950. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Tidwell R. R., Jones S. K., Geratz J. D., Ohemeng K. A., Cory M., Hall J. E. Analogues of 1,5-bis(4-amidinophenoxy)pentane (pentamidine) in the treatment of experimental Pneumocystis carinii pneumonia. J Med Chem. 1990 Apr;33(4):1252–1257. doi: 10.1021/jm00166a026. [DOI] [PubMed] [Google Scholar]
  43. Varga J. H., Wolf T. C., Jensen H. G., Parmley V. C., Rowsey J. J. Combined treatment of Acanthamoeba keratitis with propamidine, neomycin, and polyhexamethylene biguanide. Am J Ophthalmol. 1993 Apr 15;115(4):466–470. doi: 10.1016/s0002-9394(14)74448-4. [DOI] [PubMed] [Google Scholar]
  44. Walzer P. D., Kim C. K., Foy J., Linke M. J., Cushion M. T. Cationic antitrypanosomal and other antimicrobial agents in the therapy of experimental Pneumocystis carinii pneumonia. Antimicrob Agents Chemother. 1988 Jun;32(6):896–905. doi: 10.1128/aac.32.6.896. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Waring M. J., Bailly C. DNA recognition by intercalators and hybrid molecules. J Mol Recognit. 1994 Jun;7(2):109–122. doi: 10.1002/jmr.300070208. [DOI] [PubMed] [Google Scholar]
  46. Waring M. Variation of the supercoils in closed circular DNA by binding of antibiotics and drugs: evidence for molecular models involving intercalation. J Mol Biol. 1970 Dec 14;54(2):247–279. doi: 10.1016/0022-2836(70)90429-8. [DOI] [PubMed] [Google Scholar]
  47. Weston S. A., Lahm A., Suck D. X-ray structure of the DNase I-d(GGTATACC)2 complex at 2.3 A resolution. J Mol Biol. 1992 Aug 20;226(4):1237–1256. doi: 10.1016/0022-2836(92)91064-v. [DOI] [PubMed] [Google Scholar]
  48. Williamson J. Effects of trypanocides on the fine structure of target organisms. Pharmacol Ther. 1979;7(3):445–512. doi: 10.1016/0163-7258(79)90040-8. [DOI] [PubMed] [Google Scholar]
  49. Wispelwey B., Pearson R. D. Pentamidine: a review. Infect Control Hosp Epidemiol. 1991 Jun;12(6):375–382. doi: 10.1086/646360. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES